Literature DB >> 12649074

Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis.

Toshiro Matsunaga1, David C Warltier, John Tessmer, Dorothee Weihrauch, Michael Simons, William M Chilian.   

Abstract

The mechanisms underlying coronary capillary growth in response to ischemia are undefined. We hypothesized that the expression of vascular endothelial growth factor (VEGF) and angiopoietin (Ang)/Tie-2 were involved in capillary growth as an adaptation to ischemia. To test this hypothesis we measured capillary density, and the expressions of VEGF, Ang-1, Ang-2, and the Tie-2 receptor and its phosphorylation state during repetitive episodes of myocardial ischemia in chronically instrumented canines. Repetitive episodes of ischemia were induced by multiple (once/hour; 8/day), brief (2 min) occlusions of the left anterior descending coronary artery for 1, 7, 14, or 21 days. A sham group received the same instrumentation as the experimental groups but not the occlusion protocol. Collateral blood flow (microspheres) progressively increased from 9 +/- 3 to 83 +/- 10 ml. min-1. 100 g-1 on day 21. Capillary density increased at day 7 from 2378 +/- 53 (sham) to 2962 +/- 60/mm2, but it decreased to 2594 +/- 39/mm2 at day 21. Both VEGF and Ang-2 expression in myocardial interstitial fluid (Western analyses) peaked at day 3 of the repetitive occlusions but waned thereafter. In contrast the expression of Ang-1 remained relatively constant at all times in the occlusion groups. In shams, the expression of VEGF and Ang-2 was low and constant at all times. Tie-2 phosphorylation myocardial decreased decreased at day 7 but increased at 21 days of occlusions (P < 0.05). Our results indicate that capillary density was augmented by myocardial ischemia, but after development of collaterals and restoration of flow to the ischemic zone, capillary density returned to control levels. The change in capillary density paralleled with VEGF and Ang-2 expression but was inversely related to Tie-2 phosphorylation. We speculate the coronary angiogenesis is a coordinated event involving the expression of both VEGF and Ang-2 and that therapeutic angiogenic strategies may ultimately require treatment with more than a single factor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649074     DOI: 10.1152/ajpheart.00621.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome.

Authors:  Rebecca Hutcheson; Jennifer Chaplin; Brenda Hutcheson; Faye Borthwick; Spencer Proctor; Sarah Gebb; Rashmi Jadhav; Erika Smith; James C Russell; Petra Rocic
Journal:  FASEB J       Date:  2014-06-05       Impact factor: 5.191

Review 5.  Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?

Authors:  Petra Rocic
Journal:  Vascul Pharmacol       Date:  2012-02-09       Impact factor: 5.773

Review 6.  The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.

Authors:  Derek J Hausenloy; William Chilian; Filippo Crea; Sean M Davidson; Peter Ferdinandy; David Garcia-Dorado; Niels van Royen; Rainer Schulz; Gerd Heusch
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

7.  No-reflow reversibility: a study based on serial assessment of multiple biomarkers.

Authors:  Giampaolo Niccoli; Francesco Fracassi; Nicola Cosentino; Elena Falcioni; Marco Roberto; Giuseppe De Luca; Antonio Maria Leone; Francesco Burzotta; Italo Porto; Carlo Trani; Anna Severino; Filippo Crea
Journal:  J Cardiovasc Transl Res       Date:  2013-09-06       Impact factor: 4.132

8.  Spinal stenosis: assessment of motor function, VEGF expression and angiogenesis in an experimental model in the rat.

Authors:  Kazuyuki Watanabe; Shin-Ichi Konno; Miho Sekiguchi; Shin-Ichi Kikuchi
Journal:  Eur Spine J       Date:  2007-06-02       Impact factor: 3.134

9.  Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.

Authors:  Francesca Gotsch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Michael Dombrowski; Offer Erez; Nandor Gabor Than; Shali Mazaki-Tovi; Pooja Mittal; Jimmy Espinoza; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-06

10.  Myocardial interstitial fluid inhibits proliferation and cardiomyocyte differentiation in pluripotent embryonic stem cells.

Authors:  Jordan R Van Orman; Dorothee Weihrauch; David C Warltier; John Lough
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.